Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: Comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging

Japanese Journal of Radiology

Volumn 28, Issue 2, 2010, Pages 101-109

  Tozaki, Mitsuhiro ^a   Oyama, Yu ^a   Fukuma, Eisuke ^a  

^a KAMEDA MEDICAL CENTER   (Japan)

Author keywords

Breast cancer; Diffusion weighted imaging; Neoadjuvant chemotherapy; Proton MRS; Therapeutic response

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GADOLINIUM PENTETATE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 77649222386     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-009-0391-7     Document Type: Article

References (32)

1. B. Fisher A. Brown E. Mamounas S. Wieand A. Robidoux R.G. Margolese, et al. 1997 Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 2483 2493 1:CAS:528:DyaK2sXkslymsr8%3D 9215816
2. B. Fisher J. Bryant N. Wolmark E. Mamounas A. Brown E.R. Fisher, et al. 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672 2685 1:CAS:528:DyaK1cXlsFCgurg%3D 9704717
3. A. Goldhirsch J.H. Glick R.D. Gelber A.S. Coates H.J. Senn 2001 Meeting highlights: international consensus panel on the treatment of primary breast cancer J Clin Oncol 19 3817 3827 1:STN:280:DC%2BD3Mrht1Slsw%3D%3D 11559719
4. A.A. Tardivon L. Ollivier C. El Khoury F. Thibault 2006 Monitoring therapeutic efficacy in breast carcinomas Eur Radiol 16 2549 2558 10.1007/s00330-006-0317-z 16733676 (Pubitemid 44649705)
5. P.T. Weatherall G.F. Evans G.J. Metzger M.H. Saborrian A.M. Leitch 2001 MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray mammography and palpation J Magn Reson Imaging 13 868 875 10.1002/jmri.1124 1:STN:280:DC%2BD3M3pvFejuw%3D%3D 11382946 (Pubitemid 32479944)
6. S.C. Partridge J.E. Gibbs Y. Lu L.J. Esserman D. Sudilovsky N.M. Hylton 2002 Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy AJR Am J Roentgenol 179 1193 1199 12388497
7. E. Yeh P. Slanetz D.B. Kopans E. Rafferty D. Georgian-Smith L. Moy, et al. 2005 Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer AJR Am J Roentgenol 184 868 877 15728611
8. A. Rieber H. Zeitler H. Rosenthal J. Görich R. Krelenberg H.J. Brambs, et al. 1997 MRI of breast cancer: influence of chemotherapy on sensitivity Br J Radiol 70 452 458 1:STN:280:DyaK2szntFSjsg%3D%3D 9227225
9. L. Martincich F. Montemurro G. De Rosa V. Marra R. Ponzone S. Cirillo, et al. 2004 Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging Breast Cancer Res Treat 83 67 76 10.1023/B:BREA.0000010700.11092.f4 14997056 (Pubitemid 38141894)
10. N.R. Jagannathan M. Kumar V. Seenu O. Coshic S.N. Dwivedi P.K. Julka, et al. 2001 Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer Br J Cancer 84 1016 1022 10.1054/bjoc.2000.1711 1:CAS:528:DC%2BD3MXktFymtbs%3D 11308247 (Pubitemid 32448495)
11. M. Kumar N.R. Jagannathan V. Seenu S.N. Dwivedi P.K. Julka G.K. Rath 2006 Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study J Magn Reson Imaging 24 325 332 10.1002/jmri.20646 16786567 (Pubitemid 44188558)
12. S. Meisamy P.J. Bolan E.H. Baker R.L. Bliss E. Gulbahce L.I. Everson, et al. 2004 Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy: a pilot study at 4 T Radiology 233 424 431 10.1148/radiol.2332031285 15516615 (Pubitemid 39423801)
13. Y. Guo Y.Q. Cai Z.L. Cai Y.G. Gao N.Y. An L. Ma, et al. 2002 Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging J Magn Reson Imaging 16 172 178 10.1002/jmri.10140 12203765 (Pubitemid 34810055)
14. S. Sinha F.A. Lucas-Quesada U. Sinha N. DeBruhl L.W. Bassett 2002 In vivo diffusion-weighted MRI of the breast: potential for lesion characterization J Magn Reson Imaging 15 693 704 10.1002/jmri.10116 12112520 (Pubitemid 34606504)
15. J.P. Galons M.I. Altbach G.D. Paine-Murrieta C.W. Taylor R.J. Gillies 1999 Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by noninvasive diffusion magnetic resonance imaging Neoplasia 1 133 137 10.1038/sj.neo.7900009
16. U. Sharma K.K. Danishad V. Seenu N.R. Jagannathan 2009 Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy NMR Biomed 22 104 113 10.1002/nbm.1245 18384182
17. P. Therasse S.G. Arbuck E.A. Eisenhauer J. Wanders R.S. Kaplan L. Rubinstein, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280: DC%2BD3c7it1Gitg%3D%3D 10655437
18. P.A. Bottomley 1987 On restoring motion-induced signal loss in single-voxel magnetic resonance spectra Ann N Y Acad Sci 508 333 348 10.1111/j.1749-6632.1987.tb32915.x 1:STN:280:DyaL1c7kvVKqtw%3D%3D 3326459
19. J. Star-Lack S.J. Nelson J. Kurhanewicz L.R. Huang D.B. Vigneron 1997 Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING) Magn Reson Med 38 311 321 10.1002/mrm.1910380222 1:CAS:528:DyaK2sXls1Wnt7s%3D 9256113 (Pubitemid 27328261)
20. W. Huang P.R. Fisher K. Dulaimy L.A. Tudorica B. O'Hea T.M. Button 2004 Detection of breast malignancy: diagnostic MR protocol for improved specificity Radiology 232 585 591 10.1148/radiol.2322030547 15205478 (Pubitemid 38971303)
21. L. Bartella E.A. Morris D.D. Dershaw L. Liberman S.B. Thakur C. Moskowitz, et al. 2006 Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study Radiology 239 686 692 10.1148/radiol.2393051046 16603660
22. D.M. Sataloff B.A. Mason A.J. Prestipino U.L. Seinige C.P. Lieber Z. Baloch 1995 Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome J Am Coll Surg 180 297 306 1:STN:280:DyaK2M7nvFemsQ%3D%3D 7874340
23. World Health Organization classification of tumors: pathology and genetics of tumours of the breast and female genitalorgans. Lyon, France: IARC; 2003.
24. R.M. Mann C.K. Kuhl K. Kinkel C. Boetes 2008 Breast MRI: guidelines from the European Society of Breast Imaging Eur Radiol 18 1307 1318 10.1007/s00330-008-0863-7 1:STN:280:DC%2BD1czovFalsg%3D%3D 18389253
25. 18F]- fluorodeoxyglucose positron emission tomography J Magn Reson Imaging 28 420 427 10.1002/jmri.21454 18666159
26. A.P. Lin B.D. Ross 2001 Short-echo time proton MR spectroscopy in the presence of gadolinium J Comput Assist Tomogr 25 705 712 10.1097/00004728- 200109000-00007 1:STN:280:DC%2BD3MrjsFWltw%3D%3D 11584229 (Pubitemid 32861693)
27. P.S. Murphy M.O. Leach I.J. Rowland 1999 Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate Magn Reson Med 42 1155 1158 10.1002/(SICI)1522-2594(199912)42:6<1155::AID-MRM21>3.0.CO;2-N 1:CAS:528:DC%2BD3cXhsVWlsg%3D%3D 10571938
28. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration Magn Reson Imaging 16 1273 1280 10.1016/S0730-725X(98)00143-X 1:CAS:528:DyaK1MXkvVWq 9858285 (Pubitemid 29019553)
29. 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration Invest Radiol 40 405 411 10.1097/01.rli.0000167125.79212.5d 15973131 (Pubitemid 40863783)
30. R.E. Lenkinski X. Wang M. Elian S.N. Goldberg 2009 Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast Magn Reson Med 61 1286 1292 10.1002/mrm.21937 1:CAS:528:DC%2BD1MXnvVWlur0%3D 19365855
31. 1H MRS at 1.5 T Eur Radiol 15 1037 1043 10.1007/s00330-004-2475-1 15351906 (Pubitemid 41166737)
32. E.O. Aboagye Z.M. Bhujwalla 1999 Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells Cancer Res 59 80 84 1:CAS:528:DyaK1MXmsFOgtg%3D%3D 9892190